Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2026
Long-term efficacy of dupilumab versus tezepelumab in asthma: a matching-adjusted indirect comparisonKenneth R Chapman, Nick Freemantle, Patricia Guyot, et al.
Pediatric Pulmonology|July 29, 2025
Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 AsthmaLeonard B Bacharier, Jorge F Maspero, Nikolaos G Papadopoulos, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 24, 2026
Improved asthma outcomes for dupilumab plus medium-dose inhaled corticosteroids versus placebo plus high-dose inhaled corticosteroidsWilliam W Busse, Mario Castro, Njira L Lugogo, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 7, 2015
The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapiesAnne K Ellis, Mena Soliman, Lisa Steacy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 14, 2026
High Systemic Corticosteroids Burden Among Moderate-to-Severe Asthma Patients in the United StatesNjira L Lugogo, Anju T Peters, Rohit Katial, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 25, 2026
Characterization of Patients with COPD and GOLD E Classification in the United StatesSurya P Bhatt, Yiran Zhang, John White, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2026
Dupilumab in COPD: A Pooled Analysis of Emergency Department Visits, Hospital Admissions, and Systemic Corticosteroid UseSurya P Bhatt, Fernando J Martinez, Imran Satia, et al.
ERJ Open Research|August 5, 2025
Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGEGiorgio Walter Canonica, Johann Christian Virchow, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology|November 16, 2025
Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthmaIan D Pavord, Njira L Lugogo, Mario Castro, et al.
The Journal of Allergy and Clinical Immunology. Global|June 12, 2026
The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammationWilliam W Busse, Melissa Iammatteo, Mena Soliman, et al.
Pageof 2